Laparoscopic endoscopic cooperative surgery versus laparoscopic segmental resection for the treatment of endoscopically unresectable colorectal polyps: a systematic review and meta-analysis

腹腔镜内镜联合手术与腹腔镜节段切除术治疗内镜下无法切除的结直肠息肉:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Laparoscopic segmental resection (LSR) is a common treatment modality for endoscopically unresectable colorectal polyps. Laparoscopic endoscopic cooperative surgery (LECS) has emerged as a promising alternative, yet current evidence of its efficacy remains limited. OBJECTIVES: This meta-analysis aims to compare the therapeutic outcomes of LECS versus LSR for endoscopically unresectable colorectal polyps and to provide robust evidence for clinical practice. METHODS: This meta-analysis was prospectively registered on the PROSPERO website. We systematically searched PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang Data, VIP, and CBM for randomized controlled trials (RCTs) and observational studies from database inception to May 16, 2025. Data analysis was conducted using Review Manager 5.4 and Stata 18 software. Certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE). RESULTS: A total of 13 studies involving 715 patients were included in this study. Meta-analysis results showed that the LECS group had a significantly shorter length of hospital stay (MD: -2.89 days, 95% CI: -3.43 to -2.34, 13 studies, 715 patients), shorter operation time (MD: -41.62 min, 95% CI: -56.96 to -26.28, 12 studies, 593 patients), fewer postoperative overall complications (OR: 0.29, 95% CI: 0.17 to 0.49, 9 studies, 513 patients), and lower estimated blood loss (MD: - 26.12 mL, 95% CI: -37.07 to -15.17, 8 studies, 435 patients) when compared to the LSR group. CONCLUSIONS: LECS demonstrates superior short-term outcomes compared to LSR and should be considered a preeminent alternative for endoscopically unresectable colorectal polyps. However, long-term efficacy remains to be confirmed by well-designed, high-quality trials.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。